H. Ibel

650 total citations
22 papers, 433 citations indexed

About

H. Ibel is a scholar working on Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, H. Ibel has authored 22 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Pathology and Forensic Medicine and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in H. Ibel's work include Cardiac Ischemia and Reperfusion (8 papers), Metabolism and Genetic Disorders (6 papers) and Cardiac Imaging and Diagnostics (6 papers). H. Ibel is often cited by papers focused on Cardiac Ischemia and Reperfusion (8 papers), Metabolism and Genetic Disorders (6 papers) and Cardiac Imaging and Diagnostics (6 papers). H. Ibel collaborates with scholars based in Germany, Netherlands and Switzerland. H. Ibel's co-authors include Heinz‐Gerd Zimmer, U. Suchner, W. Endres, E. Gerlach, H. Schad, G Korb, M. Durán, I. Paetzke, Thomas Deufel and Y. S. Shin and has published in prestigious journals such as Science, Circulation Research and FEBS Letters.

In The Last Decade

H. Ibel

21 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Ibel Germany	13	212	131	114	111	84	22	433
G. Deleeuw United States	5	183 0.9×	187 1.4×	101 0.9×	74 0.7×	89 1.1×	6	503
Howard D. Sirak United States	16	218 1.0×	131 1.0×	49 0.4×	48 0.4×	86 1.0×	34	646
Ann F.C. Roberts United Kingdom	8	105 0.5×	153 1.2×	113 1.0×	19 0.2×	85 1.0×	12	435
Marie Milerová Czechia	13	215 1.0×	104 0.8×	92 0.8×	35 0.3×	91 1.1×	20	398
J�rgen Schrader Germany	5	185 0.9×	352 2.7×	191 1.7×	10 0.1×	142 1.7×	7	686
J. M. van der Klei‐van Moorsel Netherlands	9	586 2.8×	102 0.8×	15 0.1×	254 2.3×	110 1.3×	10	786
Kadambari Chandra Shekar United States	12	191 0.9×	95 0.7×	83 0.7×	14 0.1×	74 0.9×	18	393
Sarah Pedretti South Africa	10	121 0.6×	86 0.7×	67 0.6×	29 0.3×	23 0.3×	23	312
U Keller Germany	10	291 1.4×	197 1.5×	32 0.3×	17 0.2×	52 0.6×	32	525
M.L.P. Brückwilder Netherlands	7	242 1.1×	68 0.5×	16 0.1×	58 0.5×	77 0.9×	9	352

Countries citing papers authored by H. Ibel

Since Specialization

Citations

This map shows the geographic impact of H. Ibel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Ibel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Ibel more than expected).

Fields of papers citing papers by H. Ibel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Ibel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Ibel. The network helps show where H. Ibel may publish in the future.

Co-authorship network of co-authors of H. Ibel

This figure shows the co-authorship network connecting the top 25 collaborators of H. Ibel. A scholar is included among the top collaborators of H. Ibel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Ibel. H. Ibel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ponzone, Alberto, Francesco Porta, Laura M. Fiori, et al.. (2007). Outcome and long-term follow-up of 36 patients with tetrahydrobiopterin deficiency. Molecular Genetics and Metabolism. 93(3). 295–305. 56 indexed citations

Ibel, H., et al.. (2005). Qualitätsmanagement in der Arztpraxis. Carl Hanser Verlag GmbH & Co. KG eBooks. 1 indexed citations

Ibel, H., W. Endres, Thomas Deufel, et al.. (1993). Multiple respiratory chain abnormalities associated with hypertrophic cardiomyopathy and 3-methylglutaconic aciduria. European Journal of Pediatrics. 152(8). 665–670. 27 indexed citations

Schmidtke, Klaus, W. Endres, A. Roscher, et al.. (1992). Hartnup syndrome, progressive encephalopathy and allo-albuminaemia. European Journal of Pediatrics. 151(12). 899–903. 8 indexed citations

Müller‐Höcker, Josef, H. Ibel, I. Paetzke, et al.. (1991). Fatal infantile mitochondrial cardiomyopathy and myopathy with heterogeneous tissue expression of combined respiratory chain deficiencies. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 419(4). 355–362. 27 indexed citations

Endres, W., et al.. (1991). Bone marrow transplantation in Lesch‐Nyhan disease. Journal of Inherited Metabolic Disease. 14(2). 270–271. 8 indexed citations

Zimmer, Heinz‐Gerd, H. Ibel, & U. Suchner. (1990). Beta-adrenergic agonists stimulate the oxidative pentose phosphate pathway in the rat heart.. Circulation Research. 67(6). 1525–1534. 26 indexed citations

Endres, W., et al.. (1988). Report on a new patient with combined deficiencies of sulphite oxidase and xanthine dehydrogenase due to molybdenum cofactor deficiency. European Journal of Pediatrics. 148(3). 246–249. 26 indexed citations

Zimmer, Heinz‐Gerd, H. Ibel, U. Suchner, & H. Schad. (1984). Ribose Intervention in the Cardiac Pentose Phosphate Pathway Is Not Species-Specific. Science. 223(4637). 712–714. 39 indexed citations

10.

Zimmer, Heinz‐Gerd & H. Ibel. (1984). Ribose accelerates the repletion of the ATP pool during recovery from reversible ischemia of the rat myocardium. Journal of Molecular and Cellular Cardiology. 16(9). 863–866. 61 indexed citations

11.

Zimmer, Heinz‐Gerd & H. Ibel. (1983). Effects of ribose on cardiac metabolism and function in isoproterenol-treated rats. American Journal of Physiology-Heart and Circulatory Physiology. 245(5). H880–H886. 17 indexed citations

12.

Ibel, H., et al.. (1982). Comparative studies on the myocardial hexose monophosphate shunt in different animal species. Pflügers Archiv - European Journal of Physiology. 394(S1). R13–R13. 1 indexed citations

13.

Zimmer, Heinz‐Gerd, H. Ibel, & E. Gerlach. (1980). Significance of the hexose monophosphate shunt in experimentally induced cardiac hypertrophy. Steinkopff eBooks. 75(1). 207–213. 18 indexed citations

14.

Zimmer, Heinz‐Gerd, et al.. (1980). Long-Term Effects of Ribose on Adenine Nucleotide Metabolism in Isoproterenol-Stimulated Hearts. Advances in experimental medicine and biology. 122B. 45–50. 7 indexed citations

15.

Zimmer, Heinz‐Gerd, H. Ibel, & E. Gerlach. (1980). Significance of the hexose monophosphate shunt in experimentally induced cardiac hypertrophy. Basic Research in Cardiology. 75(1). 207–213. 18 indexed citations

16.

Ibel, H., et al.. (1980). Isoproterenol-induced enhancement of myocardial glucose-6-phosphate dehydrogenase.. PubMed. 2. 145–51. 3 indexed citations

17.

Zimmer, Heinz‐Gerd, et al.. (1980). Reduction of the Isoproterenol-Induced Alterations in Cardiac Adenine Nucleotides and Morphology by Ribose. Science. 207(4428). 319–321. 39 indexed citations

18.

Ibel, H., et al.. (1980). Studies on the hexose monophosphate shunt in the myocardium during development of hypertrophy.. PubMed. 1. 487–92. 13 indexed citations

19.

Zimmer, Heinz‐Gerd & H. Ibel. (1979). Effects of isoproterenol and dopamine on the myocardial hexose monophosphate shunt. Cellular and Molecular Life Sciences. 35(4). 510–512. 19 indexed citations

20.

Zimmer, Heinz‐Gerd & H. Ibel. (1979). Studies on the mechanism for the isoproterenol‐induced stimulation of cardiac glucose‐6‐phosphate dehydrogenase. FEBS Letters. 106(2). 335–337. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact